Request an Appointment:
Online or Call 1-888-824-0200

Disease-Specific Approach to Blood and Bone Marrow Stem Cell Transplantation

Andrzej Jakubowiak, MD and patientAndrezej Jakubowiak, MD, PhD, is director of the multiple myeloma program.

When patients come to the University of Chicago Medicine for stem cell transplant, they are cared for by a physician who has expertise not only in blood and bone marrow stem cell transplantation but also in the patient’s specific disease. Working in collaboration with other experts in their respective field, these specialists design a comprehensive treatment plan tailored to the individual patient’s unique characteristics and based on the specific disease biology.

This integrated disease-specific approach is offered for:

  • LeukemiaStem cell transplant is the best option for many types of leukemia, including myeloid and lymphoid leukemia, myelodysplastic syndrome and other myelodysplastic disorders. Our leukemia team includes internationally known clinician-researchers who use the latest combination therapies to suppress cancer cells prior to transplant.
  • Lymphoma -- When lymphoma returns after initial therapy, stem cell transplant is often the next step in an aggressive treatment course. Our lymphoma team uses new medications to control disease prior to transplantation, minimize side effects and improve survival after relapsed disease.
  • Multiple myeloma -- The hematologists/oncologists on the multiple myeloma team offer a comprehensive approach to patients with this disease. Here, novel strategies -- which include stem cell transplant -- are improving outcomes and helping patients live a better quality of life. Now considered a conventional therapy for myeloma, stem cell transplant has proven to prolong the length of remissions and increase overall survival rates. Select multiple myeloma patients are candidates to receive a stem cell transplant on an outpatient basis.